期刊文献+

HPLC测定人血浆中亚胺培南的浓度 被引量:7

Determination of Imipenem in Human Plasma by HPLC
原文传递
导出
摘要 目的 建立测定人血浆中亚胺培南浓度的HPLC方法。方法 以0.5 mol·L^-1尿素为稳定剂,以5-溴脲嘧啶为内标,血浆样品经乙腈沉淀蛋白,二氯甲烷2次提取去杂质,取水相进样。色谱柱为Atlantis C18(4.6 mm×150 mm,5 μm);流动相为甲醇-10 mmol·L^-1磷酸二氢钾溶液(pH=6.0)(4∶96);流速为1.0 mL·min^-1;柱温:25 ℃;检测波长:300 nm。结果 亚胺培南在0.5-100 mg·L^-1内线性关系良好,r=0.999 7;定量下限为0.5 mg·L^-1;平均绝对回收率 82.72%,方法回收率为87.60%-96.36%;日内、日间RSD均〈10%。结论 本方法简单、快捷、灵敏、准确,适用于亚胺培南临床血药浓度的监测。 OBJECTIVE To establish an HPLC method for the detection of imipenem in human plasma. METHODS Samples were spiked with 0.5 mol·L^-1 urea as stabilizer solution, 5-bromine urea pyrimidine as internal standard, proteins were precipitated with acetonitrile followed by extraction with dichloromethane and the upper aquous phase was injected. Separation was achieved on an Atlantis C18 column (4.6 mm×150 mm, 5 μm). The mobile phase composed of methanol and 10 mmol·L^-1 monopotassium phosphate (pH=6.0)(4∶96) with a flow rate of 1.0 mL·min^-1. The column temperature was 25 ℃. The UV detection wavelength was 300 nm. RESULTS Calibration curves of imipenem showed good linear regression in the range of 0.5-100 mg·L^-1(r=0.999 7). The lower limit of quantification of imipenem was 0.5 mg·L^-1. The mean absolute recovery was 82.72%, and the method recovery was 87.60%-96.36%. Intra- and inter-day variations were 〈10%. CONCLUSION The established method is simple, sensitive and accurate for determining imipenem in human plasma.
出处 《中国现代应用药学》 CAS CSCD 2013年第12期1349-1352,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 高效液相色谱法 亚胺培南 人血浆 HPLC imipenem human plasma
  • 相关文献

参考文献1

共引文献1

同被引文献56

  • 1吴小红,王明娟,胡昌勤.高效液相色谱法测定注射用亚胺培南/西司他丁钠含量及含量均匀度[J].中国抗生素杂志,2005,30(10):591-593. 被引量:7
  • 2汪复,张婴元.实用抗感染治疗学[M],2版.北京:人民卫生出版社,2012: 591-594.
  • 3Belzberg H,Zhu J,Cornwell EE 3rd,et al.Imipenem levels are not predictable in the critically ill patient[J].J Trauma,2004,56(1):111-117.
  • 4Keel RA,Sutherland CA,Crandon JL,et al. Stability of doripenem, imipenem and meropenem at elevated room temperatures[J]. Int J Antimicrob Agents,2011,37(2):184-185.
  • 5Xu Y,Xie W,Miller-Stein CM,et al.Hydrophilic interaction chromatography/tandem mass spectrometry for the simultaneous determination of three polar non-structurally related compounds, imipenem, cilastatin and an investigational beta-lactamase inhibitor,MK-4698, in biological matrices[J]. Rapid Commun Mass Spectrom,2009, 23(14): 2195-2205.
  • 6Viaene E,Chanteux H,Servais H,et al.Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)[J].Antimicrob Agents Chemother,2002,46(8):2327-2332.
  • 7Prescott WA Jr,Gentile AE,Nagel JL,et al.Continuous-infusion antipseudomonal beta-lactam therapy in patients with cystic fibrosis[J].P T,2011,36(11):723-763.
  • 8Legrand T,Chhun S,Rey E,et al.Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection[J].J Chromatogr B Analyt Technol Biomed Life Sci,2008,875(2):551-556.
  • 9Barbier F, Andremont A, Wolff M,et al. Hospital- acquired pneumonia and ventilator- associated pneumonia: recent advances in epidemiology and management[ J]. Curr Opin Pulm Med, 2013, 19:216 - 228.
  • 10Freire AT, Melnyk V, Kim MJ, et al. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital - acquired pneumonia[ J]. Diagn Microbiol Infect Dis, 2010,68:140 -151.

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部